- Home
- PRME vs PFN Comparison
PRME vs PFN Comparison
Compare PRME & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | PFN |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 699.5M |
| IPO Year | 2022 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PRME | PFN |
|---|---|---|
| Price | $3.56 | $6.65 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.56 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 528.1K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,632,000.00 | N/A |
| Revenue This Year | $15.20 | N/A |
| Revenue Next Year | $316.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | N/A |
| 52 Week Low | $1.11 | $6.26 |
| 52 Week High | $6.94 | $7.65 |
Technical Indicators
Market Signals| Indicator | PRME | PFN |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 23.11 |
| Support Level | $3.19 | N/A |
| Resistance Level | $4.74 | $7.56 |
| Average True Range (ATR) | 0.26 | 0.10 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 9.46 | 1.59 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.